The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.
Ho
V T
VT
Department of Adult Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Soiffer
R J
RJ
D000818:Animals; D016026:Bone Marrow Transplantation; D002469:Cell Separation / Q000379:methods; D006086:Graft vs Host Disease / Q000266:history / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation / Q000266:history / Q000401:mortality; D049673:History, 20th Century; D006801:Humans; D007938:Leukemia / Q000628:therapy; D018655:Lymphocyte Count; D012008:Recurrence; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous